United States Oral Antidiabetic Drugs Market Report 2017

January 2017 | 118 pages | ID: U2BEAEC29C1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Oral Antidiabetic Drugs

Revenue, means the sales value of Oral Antidiabetic Drugs

This report studies sales (consumption) of Oral Antidiabetic Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Eli Lilly
• Abbott
• Biocon
• Sanofi
• Sunpharma
• Novartis
• Novo Nordisk
• Merck
• Pfizer

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Sulfonylureas
• Meglitinides
• Biguanides
• Alpha-glucosidase Inhibitors

Split by applications, this report focuses on sales, market share and growth rate of Oral Antidiabetic Drugs in each application, can be divided into

• Hospital
• Clinic
• Individual
• Others

Contents

United States Oral Antidiabetic Drugs Market Report 2017

1 ORAL ANTIDIABETIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Oral Antidiabetic Drugs
1.2 Classification of Oral Antidiabetic Drugs
  1.2.1 Sulfonylureas
  1.2.2 Meglitinides
  1.2.3 Biguanides
  1.2.4 Alpha-glucosidase Inhibitors
1.3 Application of Oral Antidiabetic Drugs
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Individual
  1.3.4 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Oral Antidiabetic Drugs (2012-2022)
  1.4.1 United States Oral Antidiabetic Drugs Sales and Growth Rate (2012-2022)
  1.4.2 United States Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ORAL ANTIDIABETIC DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Oral Antidiabetic Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Oral Antidiabetic Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Oral Antidiabetic Drugs Average Price by Manufactures (2015 and 2016)
2.4 Oral Antidiabetic Drugs Market Competitive Situation and Trends
  2.4.1 Oral Antidiabetic Drugs Market Concentration Rate
  2.4.2 Oral Antidiabetic Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ORAL ANTIDIABETIC DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Oral Antidiabetic Drugs Sales and Market Share by States (2012-2017)
3.2 United States Oral Antidiabetic Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Oral Antidiabetic Drugs Price by States (2012-2017)

4 UNITED STATES ORAL ANTIDIABETIC DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Oral Antidiabetic Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Oral Antidiabetic Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Antidiabetic Drugs Price by Type (2012-2017)
4.4 United States Oral Antidiabetic Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ORAL ANTIDIABETIC DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Oral Antidiabetic Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Oral Antidiabetic Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ORAL ANTIDIABETIC DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Eli Lilly
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oral Antidiabetic Drugs Product Type, Application and Specification
    6.1.2.1 Sulfonylureas
    6.1.2.2 Meglitinides
  6.1.3 Eli Lilly Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott
  6.2.2 Oral Antidiabetic Drugs Product Type, Application and Specification
    6.2.2.1 Sulfonylureas
    6.2.2.2 Meglitinides
  6.2.3 Abbott Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Biocon
  6.3.2 Oral Antidiabetic Drugs Product Type, Application and Specification
    6.3.2.1 Sulfonylureas
    6.3.2.2 Meglitinides
  6.3.3 Biocon Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Oral Antidiabetic Drugs Product Type, Application and Specification
    6.4.2.1 Sulfonylureas
    6.4.2.2 Meglitinides
  6.4.3 Sanofi Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sunpharma
  6.5.2 Oral Antidiabetic Drugs Product Type, Application and Specification
    6.5.2.1 Sulfonylureas
    6.5.2.2 Meglitinides
  6.5.3 Sunpharma Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Oral Antidiabetic Drugs Product Type, Application and Specification
    6.6.2.1 Sulfonylureas
    6.6.2.2 Meglitinides
  6.6.3 Novartis Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
  6.7.2 Oral Antidiabetic Drugs Product Type, Application and Specification
    6.7.2.1 Sulfonylureas
    6.7.2.2 Meglitinides
  6.7.3 Novo Nordisk Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merck
  6.8.2 Oral Antidiabetic Drugs Product Type, Application and Specification
    6.8.2.1 Sulfonylureas
    6.8.2.2 Meglitinides
  6.8.3 Merck Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Pfizer
  6.9.2 Oral Antidiabetic Drugs Product Type, Application and Specification
    6.9.2.1 Sulfonylureas
    6.9.2.2 Meglitinides
  6.9.3 Pfizer Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 ORAL ANTIDIABETIC DRUGS MANUFACTURING COST ANALYSIS

7.1 Oral Antidiabetic Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Antidiabetic Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Antidiabetic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Antidiabetic Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ORAL ANTIDIABETIC DRUGS MARKET FORECAST (2017-2022)

11.1 United States Oral Antidiabetic Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Oral Antidiabetic Drugs Sales Forecast by Type (2017-2022)
11.3 United States Oral Antidiabetic Drugs Sales Forecast by Application (2017-2022)
11.4 Oral Antidiabetic Drugs Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oral Antidiabetic Drugs
Table Classification of Oral Antidiabetic Drugs
Figure United States Sales Market Share of Oral Antidiabetic Drugs by Type in 2015
Figure Sulfonylureas Picture
Figure Meglitinides Picture
Figure Biguanides Picture
Figure Alpha-glucosidase Inhibitors Picture
Table Application of Oral Antidiabetic Drugs
Figure United States Sales Market Share of Oral Antidiabetic Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure Individual Examples
Figure Others Examples
Figure United States Oral Antidiabetic Drugs Sales and Growth Rate (2012-2022)
Figure United States Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)
Table United States Oral Antidiabetic Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Oral Antidiabetic Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oral Antidiabetic Drugs Sales Share by Manufacturers
Figure 2016 Oral Antidiabetic Drugs Sales Share by Manufacturers
Table United States Oral Antidiabetic Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Oral Antidiabetic Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Oral Antidiabetic Drugs Revenue Share by Manufacturers
Table 2016 United States Oral Antidiabetic Drugs Revenue Share by Manufacturers
Table United States Market Oral Antidiabetic Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Oral Antidiabetic Drugs Average Price of Key Manufacturers in 2015
Figure Oral Antidiabetic Drugs Market Share of Top 3 Manufacturers
Figure Oral Antidiabetic Drugs Market Share of Top 5 Manufacturers
Table United States Oral Antidiabetic Drugs Sales by States (2012-2017)
Table United States Oral Antidiabetic Drugs Sales Share by States (2012-2017)
Figure United States Oral Antidiabetic Drugs Sales Market Share by States in 2015
Table United States Oral Antidiabetic Drugs Revenue and Market Share by States (2012-2017)
Table United States Oral Antidiabetic Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Oral Antidiabetic Drugs by States (2012-2017)
Table United States Oral Antidiabetic Drugs Price by States (2012-2017)
Table United States Oral Antidiabetic Drugs Sales by Type (2012-2017)
Table United States Oral Antidiabetic Drugs Sales Share by Type (2012-2017)
Figure United States Oral Antidiabetic Drugs Sales Market Share by Type in 2015
Table United States Oral Antidiabetic Drugs Revenue and Market Share by Type (2012-2017)
Table United States Oral Antidiabetic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Antidiabetic Drugs by Type (2012-2017)
Table United States Oral Antidiabetic Drugs Price by Type (2012-2017)
Figure United States Oral Antidiabetic Drugs Sales Growth Rate by Type (2012-2017)
Table United States Oral Antidiabetic Drugs Sales by Application (2012-2017)
Table United States Oral Antidiabetic Drugs Sales Market Share by Application (2012-2017)
Figure United States Oral Antidiabetic Drugs Sales Market Share by Application in 2015
Table United States Oral Antidiabetic Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Oral Antidiabetic Drugs Sales Growth Rate by Application (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Oral Antidiabetic Drugs Sales Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Oral Antidiabetic Drugs Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Oral Antidiabetic Drugs Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Oral Antidiabetic Drugs Sales Market Share (2012-2017)
Table Sunpharma Basic Information List
Table Sunpharma Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sunpharma Oral Antidiabetic Drugs Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Oral Antidiabetic Drugs Sales Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Oral Antidiabetic Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Oral Antidiabetic Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Oral Antidiabetic Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Antidiabetic Drugs
Figure Manufacturing Process Analysis of Oral Antidiabetic Drugs
Figure Oral Antidiabetic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oral Antidiabetic Drugs Major Manufacturers in 2015
Table Major Buyers of Oral Antidiabetic Drugs
Table Distributors/Traders List
Figure United States Oral Antidiabetic Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Oral Antidiabetic Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Oral Antidiabetic Drugs Production Forecast by Type (2017-2022)
Table United States Oral Antidiabetic Drugs Consumption Forecast by Application (2017-2022)
Table United States Oral Antidiabetic Drugs Sales Forecast by States (2017-2022)
Table United States Oral Antidiabetic Drugs Sales Share Forecast by States (2017-2022)